REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 138 filers reported holding REPLIMUNE GROUP INC in Q1 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,901,913 | -26.3% | 2,098,300 | 0.0% | 5.56% | -8.3% |
| Q2 2023 | $48,722,526 | +31.5% | 2,098,300 | 0.0% | 6.06% | +20.8% |
| Q1 2023 | $37,055,978 | -35.1% | 2,098,300 | 0.0% | 5.02% | -27.0% |
| Q4 2022 | $57,073,760 | +6.3% | 2,098,300 | -32.5% | 6.88% | +16.1% |
| Q3 2022 | $53,680,000 | -4.3% | 3,108,300 | -3.2% | 5.92% | -36.8% |
| Q2 2022 | $56,104,000 | +2.9% | 3,209,627 | 0.0% | 9.38% | +36.1% |
| Q1 2022 | $54,499,000 | -37.3% | 3,209,627 | 0.0% | 6.89% | -13.8% |
| Q4 2021 | $86,981,000 | – | 3,209,627 | – | 7.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
| Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
| Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
| BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
| Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
| EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
| Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
| EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
| Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |